Well Lead Medical Co., Ltd. (SHA:603309)
China · Delayed Price · Currency is CNY 11.79
-0.03 (-0.25%)
Jul 13, 2026, 3:00 PM CST
Well Lead Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,450 | 3,967 | 3,509 | 4,172 | 5,861 | 4,176 | |
Market Cap Growth | -5.23% | 13.05% | -15.90% | -28.82% | 40.35% | 28.18% |
Enterprise Value | 3,637 | 4,176 | 3,675 | 3,991 | 5,495 | 4,254 |
Last Close Price | 11.82 | 13.08 | 11.06 | 12.62 | 17.41 | 13.66 |
PE Ratio | 44.51 | 51.97 | 15.99 | 21.67 | 35.18 | 39.36 |
Forward PE | 10.94 | 80.30 | 80.30 | 80.30 | 80.30 | 80.30 |
PS Ratio | 2.10 | 2.43 | 2.33 | 3.01 | 4.30 | 3.73 |
PB Ratio | 1.88 | 2.23 | 1.84 | 2.27 | 3.37 | 2.62 |
P/TBV Ratio | 2.29 | 2.74 | 2.49 | 3.08 | 4.66 | 3.79 |
P/FCF Ratio | 21.64 | 31.96 | - | - | 27.94 | 53.53 |
P/OCF Ratio | 9.00 | 12.01 | 11.46 | 18.75 | 14.98 | 22.30 |
EV/Sales Ratio | 2.22 | 2.56 | 2.44 | 2.88 | 4.03 | 3.80 |
EV/EBITDA Ratio | 9.55 | 11.53 | 11.43 | 13.41 | 21.68 | 21.43 |
EV/EBIT Ratio | 12.43 | 14.61 | 14.42 | 17.02 | 27.87 | 28.52 |
EV/FCF Ratio | 22.81 | 33.65 | - | - | 26.20 | 54.54 |
Debt / Equity Ratio | 0.34 | 0.35 | 0.27 | 0.22 | 0.15 | 0.15 |
Debt / EBITDA Ratio | 1.65 | 1.67 | 1.54 | 1.29 | 0.99 | 1.18 |
Debt / FCF Ratio | 3.95 | 5.01 | - | - | 1.24 | 3.14 |
Net Debt / Equity Ratio | 0.09 | 0.06 | 0.02 | -0.03 | -0.25 | -0.24 |
Net Debt / EBITDA Ratio | 0.46 | 0.28 | 0.09 | -0.17 | -1.75 | -1.97 |
Net Debt / FCF Ratio | 1.07 | 0.83 | -2.95 | 0.37 | -2.12 | -5.00 |
Asset Turnover | 0.59 | 0.57 | 0.55 | 0.56 | 0.60 | 0.62 |
Inventory Turnover | 5.05 | 5.09 | 5.43 | 4.98 | 4.74 | 4.29 |
Quick Ratio | 1.38 | 1.19 | 1.32 | 1.47 | 1.70 | 1.83 |
Current Ratio | 1.83 | 1.52 | 1.67 | 1.85 | 2.08 | 2.29 |
Return on Equity (ROE) | 4.65% | 4.74% | 12.22% | 11.44% | 10.67% | 8.38% |
Return on Assets (ROA) | 6.55% | 6.27% | 5.85% | 5.87% | 5.46% | 5.15% |
Return on Invested Capital (ROIC) | 10.10% | 10.03% | 11.91% | 13.11% | 13.65% | 10.53% |
Return on Capital Employed (ROCE) | 12.80% | 12.90% | 11.00% | 10.80% | 10.30% | 8.70% |
Earnings Yield | 2.24% | 1.92% | 6.25% | 4.61% | 2.84% | 2.54% |
FCF Yield | 4.62% | 3.13% | -0.27% | -3.25% | 3.58% | 1.87% |
Dividend Yield | 5.08% | 3.82% | 4.52% | 3.96% | 1.95% | 0.99% |
Payout Ratio | 280.79% | 208.57% | 70.93% | 55.50% | 27.31% | 55.20% |
Buyback Yield / Dilution | 0.34% | -0.36% | -0.30% | 0.20% | -12.93% | 0.29% |
Total Shareholder Return | 5.42% | 3.46% | 4.22% | 4.16% | -10.98% | 1.28% |